Acute Myeloid Leukemia - PubMed (original) (raw)

Review

. 2015 Sep 17;373(12):1136-52.

doi: 10.1056/NEJMra1406184.

• PMID: 26376137
• DOI: 10.1056/NEJMra1406184

Review

Acute Myeloid Leukemia

Hartmut Döhner et al. N Engl J Med. 2015.

No abstract available

PubMed Disclaimer

Similar articles

• The combination of fludarabine, cytarabine and etoposide is an active and well-tolerated regimen in relapsed/refractory acute myeloid leukemia.
  Aldoss I, Ji L, Haider M, Pullarkat V. Aldoss I, et al. Acta Haematol. 2014;131(4):202-7. doi: 10.1159/000354820. Epub 2013 Nov 27. Acta Haematol. 2014. PMID: 24296475
• Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia.
  Hamadani M, Awan FT. Hamadani M, et al. Hematol Oncol. 2010 Mar;28(1):3-12. doi: 10.1002/hon.915. Hematol Oncol. 2010. PMID: 19645073 Review.
• Novel therapeutic strategies for AML in 2012.
  Tallman MS. Tallman MS. Hematology. 2012 Apr;17 Suppl 1:S43-6. doi: 10.1179/102453312X13336169155457. Hematology. 2012. PMID: 22507777
• [Current treatment of acute myeloid leukemia].
  Ohtake S. Ohtake S. Rinsho Ketsueki. 2012 Oct;53(10):1560-70. Rinsho Ketsueki. 2012. PMID: 23037728 Review. Japanese. No abstract available.

Cited by

• Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
  Rosenthal SH, Gerasimova A, Ma C, Li HR, Grupe A, Chong H, Acab A, Smolgovsky A, Owen R, Elzinga C, Chen R, Sugganth D, Freitas T, Graham J, Champion K, Bhattacharya A, Racke F, Lacbawan F. Rosenthal SH, et al. PLoS One. 2021 Apr 28;16(4):e0243683. doi: 10.1371/journal.pone.0243683. eCollection 2021. PLoS One. 2021. PMID: 33909614 Free PMC article.
• Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single-center retrospective study.
  Huang J, Huang F, Fan Z, Xu N, Xuan L, Liu H, Shi P, Jiang L, Zhang Y, Sun J, Liu Q. Huang J, et al. Cancer Med. 2020 Sep;9(17):6244-6255. doi: 10.1002/cam4.3290. Epub 2020 Jul 20. Cancer Med. 2020. PMID: 32686915 Free PMC article.
• Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia.
  Niu X, Rothe K, Chen M, Grasedieck S, Li R, Nam SE, Zhang X, Novakovskiy GE, Ahn YH, Maksakova I, Lai S, Zhang H, Yan J, Liu H, Zhao Y, Wu D, Ge Y, Wasserman WW, Rouhi A, Kuchenbauer F, Yip CK, Zhang Z, Jiang X. Niu X, et al. Blood. 2021 Jul 1;137(26):3641-3655. doi: 10.1182/blood.2020007651. Blood. 2021. PMID: 33786587 Free PMC article.
• Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
  Wong KK, Hassan R, Yaacob NS. Wong KK, et al. Front Oncol. 2021 Feb 25;11:624742. doi: 10.3389/fonc.2021.624742. eCollection 2021. Front Oncol. 2021. PMID: 33718188 Free PMC article. Review.
• Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin.
  Cruickshank MN, Ford J, Cheung LC, Heng J, Singh S, Wells J, Failes TW, Arndt GM, Smithers N, Prinjha RK, Anderson D, Carter KW, Gout AM, Lassmann T, O'Reilly J, Cole CH, Kotecha RS, Kees UR. Cruickshank MN, et al. Leukemia. 2017 Jan;31(1):40-50. doi: 10.1038/leu.2016.165. Epub 2016 Jun 13. Leukemia. 2017. PMID: 27443263 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • FlyBase